human THP1 cells |
Function assay |
20 uM |
1 h |
Inhibition of NOX2 in human THP1 cells assessed as downregulation of TPA-induced CD36 mRNA expression at 20 uM incubated for 1 hr prior to TPA challenge measured after 24 hrs by RT-PCR analysis |
23786520 |
MDA-MB-231 cells |
Function assay |
5 uM |
|
Inhibition of PMA-stimulated NF-kappaB signaling (unknown origin) expressed in MDA-MB-231 cells at 5 uM incubated for 16 hrs by luciferase reporter gene assay |
25190466 |
human MV4-11 cells |
Cytotoxicity assay |
|
72 h |
Cytotoxicity against human MV4-11 cells harboring FLT3 mutation after 72 hrs by tetrazolium based Ez CyTox cell viability assay, GI50=2.81 μM |
23411073 |
mouse RAW264.7 cells |
Function assay |
|
24 h |
Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced nitrite accumulation after 24 hrs by Griess reagent method, IC50=6.7 μM |
19778086 |
human H9 cells |
Function assay |
|
3 days |
Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 3 days by p24 antigen capture assay, EC50=9 μM |
8158164 |
HEK293 cells |
Function assay |
|
24 h |
Agonist activity at mouse PPARgamma expressed in HEK293 cells co-expressing with Gal4 reporter vector after 24 hrs by dual-luciferase reporter assay, EC50=24.9 μM |
24955889 |
mouse 26-L5 cells |
Proliferation assay |
|
72 h |
Antiproliferative activity against mouse 26-L5 cells after 72 hrs by MTT assay, EC50=25 μM |
12027739 |
human RS4:11 cells |
Cytotoxicity assay |
|
72 h |
Cytotoxicity against human RS4:11 cells harboring wild type FLT3 after 72 hrs by tetrazolium based Ez CyTox cell viability assay, GI50=27.9 μM |
23411073 |
mouse B16-BL6 cells |
Proliferation assay |
|
72 h |
Antiproliferative activity against mouse B16-BL6 cells after 72 hrs by MTT assay, EC50=31.6 μM |
12027739 |
human H9 cells |
Cytotoxicity assay |
|
3 days |
Cytotoxicity against human H9 cells after 3 days, IC50=35 μM |
8158164 |
human HT1080 cells |
Proliferation assay |
|
72 h |
Antiproliferative activity against human HT1080 cells after 72 hrs by MTT assay, IC |
12027739 |
mouse L929 cells |
Function assay |
|
15 mins |
Potentiation of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality preincubated for 15 mins before TNFalpha addition measured after 24 hrs by crystal violet staining |
9287415 |
mouse RAW264.7 cells |
Function assay |
|
|
Inhibition of COX2 protein expression in mouse RAW264.7 cells, IC50=0.5 μM |
16038536 |
human H295R cells |
Function assay |
|
|
Inhibition of aromatase expressed in human H295R cells, IC50=1 μM |
18778944 |
HEK293 FS cells |
Function assay |
|
|
Inhibition of NOX4 expressed in HEK293 FS cells assessed as H2O2 production by H2O2/Tyr/LPO assay, IC50=1.13 μM |
20731357 |
human HeLa cells |
Function assay |
|
|
Inhibition of MRP1 transfected in human HeLa cells assessed as inhibition of [3H]LTC4 transport by rapid filtration assay, Ki=2.4 μM |
19725578 |
human mast cells |
Function assay |
|
|
Inhibition of SYK in human mast cells assessed as reduction in mast cell degranulation, EC50=3 μM |
21354800 |
MDCK cells |
Function assay |
|
|
Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining, IC50=3.1 μM |
21354800 |
human MDA-kb2 cells |
Function assay |
|
|
Antagonist activity at androgen receptor in human MDA-kb2 cells assessed as inhibition of DHT-induced luciferase activity by luciferase reporter gene assay, IC50=5.2 μM |
19592245 |
MCF-7 MX cells |
Function assay |
|
|
Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining, IC50=5.9 μM |
21354800 |
MDCK cells |
Cytotoxicity assay |
|
|
Cytotoxicity against MDCK cells by MTT assay, CC50=39.59 μM |
18640042 |